|
Status |
Public on Feb 16, 2019 |
Title |
Prediction for the development of new distant metastases using serum microRNAs in patients with metastatic breast cancer treated with eribulin |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by array
|
Summary |
The combination of serum miRNAs could be a classifier for predicting the development of new distant metastasis in breast cancer patients during the treatment of eribulin
|
|
|
Overall design |
Serum microRNA profiles and clinical characteristics of 147 woman with breast cancer
|
|
|
Contributor(s) |
Tsushita N, Shimomura A, Matsuzaki J, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Shimizu C, Tamura K, Ochiya T |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Feb 15, 2018 |
Last update date |
Feb 17, 2019 |
Contact name |
Ichikawa Makiko |
E-mail(s) |
makiko.ichikawa.d3@mail.toray
|
Organization name |
Toray Industries, Inc.
|
Lab |
New Frontiers Research Laboratories
|
Street address |
6-10-1
|
City |
Kamakura |
State/province |
Kanagawa |
ZIP/Postal code |
248-0036 |
Country |
Japan |
|
|
Platforms (1) |
|
Samples (147)
|
|
Relations |
BioProject |
PRJNA434193 |